KRT19 and breast cancer: Similarly, in a large cohort of Chinese BC patients (n = 1083) more than 73% presented epithelial-mesenchymal phenotype of CTCs based on the expression of EpCAM, CK8, CK18 and CK19 as epithelial, and VIM and TWIST1 as mesenchymal markers [44].